Global Pharma Labs, Inc.

Exited
CIK: 1690824•DE•Tier2

Equity (common or preferred stock) · Audited · Wholesale · SIC 5047

$40M
Qualified
maximum offering price, as qualified
$54.4K
Reported Sold
1-Z 2024-05-28
7
Filings
across 2 offerings

Equity Classes

TypeClassOutstanding
commoncommon Stock50,500,000
preferredPreferred Stock0

Service Providers

RoleProviderCRD
auditorM&K CPAS PLLC—
underwriterCrowdVest Securities, LLC000288827

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedIssuer PortionSelling HoldersPrior 12mo QualifiedConcurrent OfferingSupplementsLast Supplement
024-1065352016-12-142020-01-222017-02-132017-02-13$1.0040,000,00054,4004,000,00050,500,000$40M$54.4K$30M$10M$0$012018-04-11

Reporting & Exit

Filed under the issuer’s Regulation A reporting number

File NumberFormFiledSales CommencedSecurities SoldQualified Sold
24R-000721-Z2024-05-282017-02-1354,40030,000,000

Current Reports

Filing DateFormEventItems
2023-09-081-UFundamental Change1
2018-12-211-UChange of Auditor4
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings